At this page you will find information about Arcomas business and financial position. The information at this page is aimed at shareholders and potential investors.
Arcomas nytillträdde VD Mattias Leire intervjuas av aktieanalytiker Hjalmar Jernström från Erik Penser Bank. Intervjun berör Mattias bakgrund och Arcomas nyligen publicerade Q1-rapport.
Bolagsstämma 2023
See our company presentation and learn more about Arcoma and our market.
Lars Kvarnhem, born in 1972, has approximately 20 years of experience in global management and business development of companies and business processes within the MedTech industry.
Previous operational roles have been, among others:
Works exclusively as an investor, primarily in the field of Medical Technology. Today Lars holds several board assignments which includes chairman of the board of Arcoma AB (publ), Stille (publ), Absorbets AB, Absorbest Holding AB, Swevet AB, Swevet Holding AB, Reison Medical AB, Part Production AB, Priego AB and Ovon AB, better known as MrCap. Board member Cavis Technologies.
Year of birth 1972
Chairman since 2017
Shares 1 321 925 (2022-12-31) through Priego AB
Other assignments: Chairman of the board of Swevet AB, Reison Medical AB and Ovon AB, better known as MrCap.
Lars is dependent in relation to major shareholders.
Mats Thorén has extensive experience in the medical technology sector, including with Handelsbanken Capital Markets as an account executive for the health sector in Corporate Finance, as an analyst in the biotechnology and medical technology at Enskilda Securities as well as Partner at Catella Healthcare AB. Previous board appointments include inter alia C-Rad AB, Cellartis AB and MIP Technologies AB.
Year of birth 1971
Member/deputy 2012/2010
Shares 668 000 (2022-12-31) directly and through Vixco Capital AB Independent in relation to major shareholders
Other assignments Board member of: Pulsetten AB, Vixco Capital AB, Arcoma Incentive AB and board substitute for Eggelbertus Holding AB.
Mats is independent in relation to major shareholders.
Jan Wahlström, born in 1967, has extensive experience from leading positions at international companies in medical technology, life science and laboratory instruments. He is the CEO of Mabtech AB since May 2022.
Previous assignments Jan has held are CEO of Elos Medtech, CEO of Biolin Scientific and Chairman of the Board of Insplorion AB.
Year of birth 1967
Member since 2022
Shares 70 000 (2022-12-31)
Other assignments: Jan Wahlström’s other assignments include: Chairman of the Board of Mablax AB, Board member of Alexam AB, Mabtech AB, CEO of Mabtech AB and Mabtech group holding AB.
Jan Wahlström does not hold any shares in the company and is considered to be independent both in relation to the company, its management and in relation to its major shareholders.
Mattias Leire has extensive experience from leading positions, including the last 9 years within Atos Medical.
Mattias has a background as a consultant at McKinsey and Atos Medical, where he held several international roles. These have included CEO roles within subsidiaries, VP & General Manager, VP Business Finance and VP Tracheostomy. Mattias has been involved in several acquisitions and also the sale of Atos Medical from EQT to PAI Partners.
Year of birth 1981
Employeed since 2023
Other assignments None
Own and related party shares 133 500
Stock options 130 000 (2022/25)
Contact info mattias.leire@arcoma.se
Johan Dahlberg has a master’s degree from Lund University and experience in most roles in finance, such as Business Controller, Accounting Manager and Finance Manager.
Most recently, he came from a business-related role at BIMobject, where he mainly worked with business follow-up. Prior to BIMobject, Johan worked for seven years at Qlik, a leading company in Business Intelligence, including the role of Finance Manager for Qlik’s Nordic sales companies.
Year of birth 1984
Employeed since 2022
Other assignments None
Own and related party shares 0
Contact info johan.dahlberg@arcoma.se
Johan Henningsson has a bachelor in mechanical engineering at Linné University. Johan has a background as a mechanical engineer at Arcoma.
Year of birth 1971
Employed since 1994, in current position since 2014.
Other assignments None
Own and related party shares 7254
Contact info johan.henningsson@arcoma.se
Linda holds a Master of Science in Engineering from Linköping University of Technology and experience as product manager at Bombardier Transportation and from employment within Radiological Physics at Sahlgrenska University Hospital.
Year of birth 1974
Employed since 2008, in her current position since 2011
Other assignments None
Own and related party shares None
Contact info linda.ungsten@arcoma.se
Nicklas Johansson has background as manufacturing manager, and workshop manager at Fläkt Woods and production planner at Arcoma AB.
Year of birth 1967
Employed since 2003, in current position since 2016
Other assignments None
Own and related party shares 14 000
Contact info nicklas.johansson@arcoma.se
Jesper Lindroos has extensive experience from the medical technology and manufacturing industry and comes most recently from Getinge Group where he held the position as Chief Project Manager. He has a Master of Science in Mechanical Engineering from Lund University and joined Arcoma during 2020.
Year of birth 1984
Employed since 2020
Other assignments None
Own and related party shares None
Contact info jesper.lindroos@arcoma.se
Henrik Blomdahl has over 20 years of experience in the medical technology industry. Most recently, Henrik comes from Invacare Rea AB, where he had the role of QA/RA Manager Nordics.
Prior to that he worked as a quality technician at Getinge Disinfection in Växjö, focusing on supplier quality, project management and internal and external audits.
Employed since 2021
Other assignments None
Own and related party shares None
Contact info henrik.blomdahl@arcoma.se
According to Articles of Association of Arcoma AB:
Main Share |
Percentage of |
|
Linc AB |
24,99% |
|
Sunstone Life Science Ventures Fund II K/S |
20,61% |
|
Priego AB |
10,03% |
|
Avanza Pension |
5,61% | |
Mats Thorén via bolag |
5,07% | |
For information on insider trading, refer to the Financial Supervisory Authority’s website: https://www.fi.se/en/
Questions for the Investor Relations department can be emailed to ir@arcoma.se or submitted by clicking on the button below.
Erik Penser Bank AB (publ) is the companies certified adviser
Apelbergsgatan 27, Box 7405, 103 91 Stockholm
Phone +46 8 463 80 00
We develop, produce and provide complete radiology solutions worldwide with the mission to improve care for the patient and work environment for the user.